DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: TYSABRI (natalizumab)
       *****************************************************
       #Post#: 2542--------------------------------------------------
       (Abst.) Long-term disease activity and disability progression in
       RRMS patients on Tysabri
   DIR By: agate
       Date: June 8, 2019, 1:32 pm
       ---------------------------------------------------------
       Not much information about just how the patients taking Tysabri
       (or other MS drugs) are doing over time but this research
       concludes:
       --- Quote ---
       > When taking into account early inflammation and the impact of
       natalizumab on disease activity during the initial treatment
       phase, a higher than expected proportion of patients showed
       disability progression.
       >
       --- End Quote ---
       From PubMed, June 8, 2019--"Long-term disease activity and
       disability progression in RRMS patients on natalizumab" by
       researchers in Amsterdam, including two who are well known in MS
       research--Barkhof, Uitdehaag:
  HTML https://www.ncbi.nlm.nih.gov/pubmed/31174043
       *****************************************************
       Page 1 of 1